This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Antia Therapeutics S.a., Centre Hospitalier Universitaire Vaudois, Centre National De La Recherche Scientifique. Active years: 2005-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 27 
2 out of 5,383 
Years Active: 2005-2020
Title: Innovative Contributions of Eric Doelker in Cancer Treatment
Introduction
Eric Doelker, an accomplished inventor based in Conches, Switzerland, has made significant strides in the field of medical innovation. With a total of five patents to his name, his work primarily focuses on improving methodologies for treating solid tumor cancers through advanced chemoembolization techniques.
Latest Patents
Among his latest inventions are two notable patents related to chemoembolization compositions that feature anti-angiogenic agents. These inventions involve the development of compositions for delivering these agents effectively. The methods proposed for preparing these compositions are critical, as they enhance the treatment options available for patients suffering from solid tumors. His work not only addresses the technical challenges involved in delivering anti-cancer agents but also emphasizes the importance of targeted treatment in oncology.
Career Highlights
Eric Doelker has lent his expertise to several organizations throughout his career. He has worked with Antia Therapeutics S.A., a company known for its dedication to advancing cancer therapies, and Université Claude Bernard Lyon 1, a prestigious institution renowned for its research contributions. His roles in these organizations have allowed him to be at the forefront of medical innovation, significantly impacting the landscape of cancer treatment.
Collaborations
Throughout his career, Eric has collaborated with notable colleagues, including Olivier Jordan and Yves Chevalier. These collaborations have enriched his research and development work, leading to the creation of groundbreaking patents that push the boundaries of current medical practices.
Conclusion
Eric Doelker's inventive contributions to cancer treatment exemplify the vital role innovation plays in healthcare. With his focus on delivering advanced chemoembolization compositions, he not only enhances therapeutic options but also inspires future developments in the medical field. His work serves as a reminder of the importance of collaboration and dedication in achieving meaningful advancements in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile